Senior columnist at the Washington Examiner and resident fellow at the American Enterprise.
Tim Carney on KCRW
More from KCRW
Biden Followed Doctors' Orders – and still got cancer
Health & WellnessEvidence-based recommendations from groups like the US Preventive Services Task Force are only as effective as the screening tools currently available.
Trump, Musk have public spat over the “Big Beautiful Bill”
PoliticsDonald Trump and Elon Musk’s whirlwind bromance comes to an end. Plus, why are Israel and the UN at odds over a new humanitarian aid group in Gaza?
How much would Hollywood suffer if China blocks film releases?
EntertainmentChina is limiting the number of Hollywood films in response to President Donald Trump’s tariffs.
Squash at Universal, Swimming at SoFi. LA Olympics venue list is out
SportsTouting the 2028 Olympics as a “no-build” Games, the final venue line-up puts many sporting events at some of LA’s most iconic sites.
Trump tries to tariff the US to greatness — will it work?
PoliticsThe president reversed course on his tariff plan hours after it took effect. Can he bring back the nostalgic economic prosperity voters desire?
Is Trump benefitting from a lack of trust in politicians?
PoliticsPresident Trump invites a few high rolling guests to dinner. Will there be political costs for Trump’s handling of Ukraine? Plus, should we regulate temptation?
Unprofessional Behaviors: Catching Bad Habits Early
Health & WellnessMedical schools must address unprofessional behavior early, as student misconduct often predicts future disciplinary issues and patient harm.
China to limit US film imports: Big financial hit to Hollywood?
ArtsChina says it’s limiting U.S. films being released there, in response to Trump’s tariffs. Hollywood has already been hit by worker strikes, streaming wars, and COVID shutdowns.
24. The Hunt for a Journalist’s Killer
InternationalA group of reporters recently uncovered a closely held secret: the identity of the Israeli soldier who shot and killed renowned veteran journalist Shireen Abu Akleh in 2022.